Join a panel of experts from AstraZeneca, University of Pennsylvania School of Medicine, and Regional Cancer Care Associates for an upcoming webinar on the state of breast cancer research today. Tune in for a discussion on: - How organizations across the healthcare industry are tackling complex clinical decision making - The use of #AI to accelerate #breastcancer research and clinical practice - Treatment selection, sequencing, and the increasingly critical role of genomic testing 📅 NEXT WEEK: Tues, July 23 12-1 PM ET Secure your spot & ask our panel of experts your questions directly. Register & submit questions now: http://spkl.io/60494Cr3V
Flatiron Health’s Post
More Relevant Posts
-
"Transforming cancer care." Foundation Medicine provides comprehensive genomic profiling to identify the genetic mutations driving an individual's cancer, facilitating personalized treatment options. Their advanced diagnostic tests and services support patients, physicians, and researchers in making informed decisions to improve cancer care outcomes. Learn more: https://lnkd.in/ggUv_86g #CancerCare #GenomicProfiling #SoHCSpotlights
To view or add a comment, sign in
-
Sign up for the Prognos Health webinar to learn more about personalized medicine and the adoption of targeted therapies for individual cancer patients #personalizedmedicine #oncology #genomicmedicine
Join us with the Genomic Testing Cooperative on February 8 at 11:00am EST / 8:00am PST to discuss trends in cancer diagnostics and how Advancements in Comprehensive Genomic Profiling (CGP) and Next Generation Sequencing (NGS) are driving personalized medicine and the adoption of targeted therapies for individual patients in cancer care today. Register here: February 8: Webinar with the Genomic Testing Cooperative https://bit.ly/48N0Xms Mark Reis Jeffrey Owen Ahmad Charifa
To view or add a comment, sign in
-
Please register for this upcoming webinar highlighting emerging trends in precision medicine and diagnostic testing.
Join us with the Genomic Testing Cooperative on February 8 at 11:00am EST / 8:00am PST to discuss trends in cancer diagnostics and how Advancements in Comprehensive Genomic Profiling (CGP) and Next Generation Sequencing (NGS) are driving personalized medicine and the adoption of targeted therapies for individual patients in cancer care today. Register here: February 8: Webinar with the Genomic Testing Cooperative https://bit.ly/48N0Xms Mark Reis Jeffrey Owen Ahmad Charifa
To view or add a comment, sign in
-
We want to conclude Lung Cancer Awareness Month with a message of hope from Tony Mok, a medical oncologist and professor at the Chinese University of Hong Kong. While we know more than ever about biomarkers of #LungCancer, comprehensive genomic profiling can help patients with lung cancer get much-needed personalized treatments. Hear more from Tony Mok: https://bit.ly/3sVhcy6
Benefits of biomarker testing for patients with lung cancer
To view or add a comment, sign in
-
Concluding the month hearing thoughts from Dr. Tony Mok talking about the amazing progress in lung cancer testing and targeted therapy. What's next - front line testing!
We want to conclude Lung Cancer Awareness Month with a message of hope from Tony Mok, a medical oncologist and professor at the Chinese University of Hong Kong. While we know more than ever about biomarkers of #LungCancer, comprehensive genomic profiling can help patients with lung cancer get much-needed personalized treatments. Hear more from Tony Mok: https://bit.ly/3sVhcy6
Benefits of biomarker testing for patients with lung cancer
To view or add a comment, sign in
-
Join the Webinar for a great discussion on the advancement of cancer diagnostics for improving patient outcomes through actionable insights. #pharma #oncology #biotech #bigpharma #precisionmedicine
This Thursday! Don't miss out... Join us with the Genomic Testing Cooperative on February 8 at 11:00am EST / 8:00am PST to discuss trends in cancer diagnostics and how Advancements in Comprehensive Genomic Profiling (CGP) and Next Generation Sequencing (NGS) are driving personalized medicine and the adoption of targeted therapies for individual patients in cancer care today. Register here: February 8: Webinar with the Genomic Testing Cooperative https://bit.ly/3HMnDr8 Unable to attend? Use the form above and indicate "send me the recording" and we'll send the webinar your way in 48 hours.
To view or add a comment, sign in
-
Neurogeneticist. Director at Center for Applied and Translational Genomics(CATG), Associate Professor, MBRU, Dubai Health. Associate Investigator, TCAG, SicKids, Toronto,Canada. Founder at GenomeArc Inc., Toronto, Canada
💫 Liquid biopsy is an intriguing development in genomic technology. The field struggles with sensitivity and specificity in establishing its diagnostic and therapeutic effectiveness across different cancer types. One of the primary hurdles is the lack of interpretive algorithms needed to extract life-saving insights from ctDNA detected variants. GenomeArc's Spectra have developed interesting algorithms, offering potential improvements in predictive diagnosis, pharmacogenomics, and cellular progression analysis. Excited to witness future breakthroughs and the growing impact of liquid biopsy in the fight against cancer, potentially even before it manifests. 💫 GenomeArc Horizon Spectra: https://lnkd.in/dzq25Q74 #liquidbiopsy #cancer #genomics
To view or add a comment, sign in
-
Managing Director, Strategy & Solutions, at Amazon Web Services (AWS) | Driving healthcare transformation via strategic, science-backed innovation
🧬 Researchers from the University of Chicago and Northwestern University have developed a groundbreaking DNA-based test that can identify cancer from minimal DNA fragments in blood samples. Their innovative approach, known as linear-amplification based bisulfite sequencing (LABS), offers a more sensitive, non-invasive alternative to traditional biopsies. This advancement could significantly increase early detection rates, improving patient outcomes and reducing the overall healthcare burden. Read more about how this technique promises to transform cancer diagnostics. #HealthcareInnovation #CancerResearch #DNASequencing Read more: https://lnkd.in/eDzDRtHb
To view or add a comment, sign in
-
Join Dr. Rick Greene and guests Thomas Brown, MD, MBA, Chief Medical Officer and Jennifer Jurivich, Senior Vice President Health Systems, two leaders at Syapse as they discuss the importance of CTRs and the benefit of combining cancer registry data with genomic and outcomes data to optimize cancer treatments, reduce variation in care and generate novel evidence & developmental therapeutics in cancer care. Tune in to hear how you can achieve more with your cancer registry data https://lnkd.in/ghw5pXAE
To view or add a comment, sign in
-
Three strong advocates for CTRs. Listen to how we play an important part in Syapse’s mission.
Join Dr. Rick Greene and guests Thomas Brown, MD, MBA, Chief Medical Officer and Jennifer Jurivich, Senior Vice President Health Systems, two leaders at Syapse as they discuss the importance of CTRs and the benefit of combining cancer registry data with genomic and outcomes data to optimize cancer treatments, reduce variation in care and generate novel evidence & developmental therapeutics in cancer care. Tune in to hear how you can achieve more with your cancer registry data https://lnkd.in/ghw5pXAE
To view or add a comment, sign in
77,447 followers